Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-2-9
pubmed:abstractText
To determine the safety of rituximab, to provide preliminary data regarding the potential efficacy of rituximab, and to investigate the effects of rituximab on autoimmunity and fibrosis in patients with diffuse cutaneous systemic sclerosis (dcSSc).
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-10366112, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-10836913, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-12045259, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-14530402, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-16790698, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-16790699, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-16874783, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-17075814, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-17195236, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-17328049, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-17581616, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-17610318, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-17763433, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-18050222, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-21107765, http://linkedlifedata.com/resource/pubmed/commentcorrection/19180481-7378088
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0004-3591
pubmed:author
pubmed:issnType
Print
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
578-83
pubmed:dateRevised
2011-1-20
pubmed:meshHeading
pubmed-meshheading:19180481-Adult, pubmed-meshheading:19180481-Antibodies, Monoclonal, pubmed-meshheading:19180481-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:19180481-Autoantibodies, pubmed-meshheading:19180481-Autoimmunity, pubmed-meshheading:19180481-B-Lymphocytes, pubmed-meshheading:19180481-Cell Survival, pubmed-meshheading:19180481-Female, pubmed-meshheading:19180481-Humans, pubmed-meshheading:19180481-Immunologic Factors, pubmed-meshheading:19180481-Injections, Intravenous, pubmed-meshheading:19180481-Leukocyte Count, pubmed-meshheading:19180481-Lymphocyte Depletion, pubmed-meshheading:19180481-Male, pubmed-meshheading:19180481-Middle Aged, pubmed-meshheading:19180481-Pilot Projects, pubmed-meshheading:19180481-Respiratory Function Tests, pubmed-meshheading:19180481-Scleroderma, Diffuse, pubmed-meshheading:19180481-Skin
pubmed:year
2009
pubmed:articleTitle
B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis.
pubmed:affiliation
Boston University School of Medicine, Boston, Massachusetts 02118, USA. lafyatis@bu.edu
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural